Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY 4.0Frontiers in Cardiovascular Medicine

Association of the red cell distribution width/albumin ratio with 6-month readmission risk in heart failure patients

  • Hanyu Wang1
  • Lihua Yang1
  • Zhengye Liu1
  • Yitian Wang1
  • Xing Lv1
  • Ruina Ma2
  • Min Li3
  1. 1College of Basic Medicine, the Fourth Military Medical University
  2. 2Department of Pulmonary and Critical Care Medicine, the Second Affiliated Hospital, the Fourth Military Medical University
  3. 3Department of Critical Care Medicine, the Second Affiliated Hospital, the Fourth Military Medical University
Read full textPDFDOICite

Abstract

Background: Readmission due to heart failure (HF) remains a major clinical and economic challenge. The red cell distribution width-to-albumin ratio (RAR) has been proposed as a novel biomarker reflecting chronic inflammation, nutritional status, and multi-organ involvement in cardiovascular diseases. However, the association between RAR and readmission risk, particularly in Asian populations with HF, remains unclear. This study aimed to evaluate the relationship between RAR levels and the 6-month readmission risk among Chinese patients with heart failure.

Methods: We conducted a retrospective cohort study using data from the Zigong Heart Failure Database, which included 2008 patients hospitalized for HF between December 2016 and June 2019. After excluding patients with missing RDW, albumin, or readmission data, 1854 patients were included in the final analytical cohort. Based on RAR values, patients were divided into four quartiles. Multivariable Cox proportional hazards regression models were used to assess the association between RAR and 6-month readmission risk, adjusting for demographics, clinical parameters, comorbidities, and medications. Subgroup analyses were performed to examine the consistency of associations across different patient characteristics.

Results: The overall 6-month readmission rate was 38.5% (714/1854). Patients in higher RAR quartiles had a significantly greater risk of readmission than those in lower quartiles ( P = 0.0025). In unadjusted analyses, each unit increase in RAR was associated with a 57% higher risk of 6-month readmission (HR 1.57, 95% CI: 1.27–1.93, P < 0.001). This association remained significant after adjusting for confounding variables (HR 1.52, 95% CI: 1.21–1.92, P < 0.001). After full adjustment, patients in the highest quartile (Q4) had a 39% higher risk of readmission compared with those in the lowest quartile (Q1) (HR 1.39, 95% CI: 1.10–1.76, P < 0.001). Subgroup analyses showed consistent associations across sex, age, BMI, NYHA classification, and medication use, with no significant interactions observed.

Conclusion: Elevated RAR was independently associated with an increased 6-month readmission risk among Chinese patients with HF. As a simple and cost-effective biomarker, RAR may enhance risk stratification and inform clinical decision-making in HF management, potentially improving patient outcomes and reducing healthcare burden.

Related

  1. Association of the Red Blood Cell Distribution Width-to-Albumin Ratio with Renal Outcomes in Chinese Patients with IgA Nephropathy
    Lingqiu Dong, Zhanxiong Shen, Siqing Wang +2
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  2. Association of red cell distribution width-to-albumin ratio with ICU outcomes in patients with aortic dissection
    Chen Li, Xingping Lv, Yezhou Shen +3
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefEurope PMCPMC
  3. Association and Discriminative Performance of a Bilirubin-D-Dimer-Albumin Index for LVEF <45% in Patients with Heart Failure: A Single-Centre Retrospective Study.
    Shiraz Rafiq, Jannat Atajanova, He Pengyi
    Vascular health and risk managementPeer-reviewedCC BY-NCFull textCardiovascular medicineEurope PMCPMC
  4. Multidisciplinary nurse-led transitional care and 30-day readmission in patients with heart failure: a retrospective cohort study
    Qiang Fan, Han Liu, Yang Yu +3
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Cardiovascular medicineCrossref
  5. The red blood cell distribution width-to-albumin ratio and 28-day mortality in patients with severe cardiogenic shock: a retrospective cohort study based on MIMIC-IV with single-center external validation
    Yi Ou, Xiongwei Meng, Dan Zhang +3
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{wang2026association,
  title = {{Association of the red cell distribution width/albumin ratio with 6-month readmission risk in heart failure patients}},
  author = {Hanyu Wang and Lihua Yang and Zhengye Liu and Yitian Wang and Xing Lv and Ruina Ma and Min Li},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  month = oct,
  doi = {10.3389/fcvm.2026.1842863},
  url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1842863/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Association of the red cell distribution width/albumin ratio with 6-month readmission risk in heart failure patients
AU  - Hanyu Wang
AU  - Lihua Yang
AU  - Zhengye Liu
AU  - Yitian Wang
AU  - Xing Lv
AU  - Ruina Ma
AU  - Min Li
PY  - 2026
DA  - 2026/10/15
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2026.1842863
UR  - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1842863/full
AB  - Background: Readmission due to heart failure (HF) remains a major clinical and economic challenge. The red cell distribution width-to-albumin ratio (RAR) has been proposed as a novel biomarker reflecting chronic inflammation, nutritional status, and multi-organ involvement in cardiovascular diseases. However, the association between RAR and readmission risk, particularly in Asian populations with HF, remains unclear. This study aimed to evaluate the relationship between RAR levels and the 6-month readmission risk among Chinese patients with heart failure.  Methods: We conducted a retrospective cohort study using data from the Zigong Heart Failure Database, which included 2008 patients hospitalized for HF between December 2016 and June 2019. After excluding patients with missing RDW, albumin, or readmission data, 1854 patients were included in the final analytical cohort. Based on RAR values, patients were divided into four quartiles. Multivariable Cox proportional hazards regression models were used to assess the association between RAR and 6-month readmission risk, adjusting for demographics, clinical parameters, comorbidities, and medications. Subgroup analyses were performed to examine the consistency of associations across different patient characteristics.  Results: The overall 6-month readmission rate was 38.5% (714/1854). Patients in higher RAR quartiles had a significantly greater risk of readmission than those in lower quartiles ( P = 0.0025). In unadjusted analyses, each unit increase in RAR was associated with a 57% higher risk of 6-month readmission (HR 1.57, 95% CI: 1.27–1.93, P &lt; 0.001). This association remained significant after adjusting for confounding variables (HR 1.52, 95% CI: 1.21–1.92, P &lt; 0.001). After full adjustment, patients in the highest quartile (Q4) had a 39% higher risk of readmission compared with those in the lowest quartile (Q1) (HR 1.39, 95% CI: 1.10–1.76, P &lt; 0.001). Subgroup analyses showed consistent associations across sex, age, BMI, NYHA classification, and medication use, with no significant interactions observed.  Conclusion: Elevated RAR was independently associated with an increased 6-month readmission risk among Chinese patients with HF. As a simple and cost-effective biomarker, RAR may enhance risk stratification and inform clinical decision-making in HF management, potentially improving patient outcomes and reducing healthcare burden.
SN  - 2297-055X
ER  -